Morgan Stanley Signals Potential Turnaround for Franklin Resources BEN Spiritual Tourism in Himalayan Foothills Ashram Lifestyle Attracts Global Interest Market Implications Vincent Bollors Media Influence Sparks Industry Concerns EU Fund Proposed as Potential Safeguard Stocks Surge Amid Strong Earnings and Potential Iran Deal Key Events to Watch Stellantis Outlines Turnaround Strategy Prediction Markets Face Regulatory Scrutiny Oura Files for IPO CNBC Morning Brief European Rightwing Populists Shifting Perceptions on China 4 Key Insights GDS Q1 2026 Earnings Massive EPS Beat but Stock Slips on Revenue Uncertainty MNSBP Q1 2026 Earnings EPS Surges Past Estimates by 2418 Concentrix CNXC Q1 2026 Earnings EPS Miss and Revenue NonDisclosure Weigh on Sentiment ERAS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Climbs Zoetis ZTS Q1 2026 Earnings EPS Misses Estimates Despite Strong Stock Performance Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 Sadot Group Inc SDOT Surges 6 as Buyers Test Key Resistance Near 321 Celldex Therapeutics CLDX Edges Lower Amid Consolidation Near Key Support XWELL Inc XWEL Edges Lower in Quiet Trading Support Level in Focus OKYO Pharma Shows Cautious Uptick Amid Biotech Sector Movements Kayne Anderson Energy Infrastructure Fund KYN Nears Support After Modest Decline STNE Q1 2026 Earnings EPS Misses Estimates Amidst Operational Progress Stock Declines Slightly VABK Q1 2026 Earnings Reported EPS of 097 Drives Positive Stock Movement Sea Limited SE Q1 2026 Earnings EPS Misses Estimates as Gaming and ECommerce Face Headwinds Everspin Technologies Q1 2026 Earnings EPS Beat Drives Positive Market Response Harte Harte Hanks Inc Q2 2025 Earnings Narrowed Loss Amid Strategic Transformation BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline VolitionRx Limited VNRX Gains Attention as a TopRated Penny Stock Among Wall Street Analysts XWEL Q3 2023 Earnings Significant EPS Miss with No Reported Revenue Delta Air Lines Edges Higher Near Resistance DAL Tests Key Level After Modest Gain Southern Company Preferred SOJD Holds Steady Support Levels in Focus Caesars Entertainment CZR Edges Up 14 Tests Key Resistance Zone Amid Mixed Sector Signals Extreme Networks EXTR Surges Over 7 Key Levels to Watch After a Strong Rebound C4 Therapeutics CCCC Gains 114 as Stock Tests Key Resistance Near 374 Interactive Brokers Group IBKR Gains Ground as Uptrend Continues First Trust Mortgage Income Fund FMY Edges Higher Amid Steady Income Appeal Four Seasons Education FEDU Surges 79 as Stock Tests Key Resistance Near 1146